OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis
Pei‐Ling Hsu, Chun‐Wei Chien, Yen-An Tang, et al.
Science Advances (2023) Vol. 9, Iss. 15
Open Access | Times Cited: 19

Showing 19 citing articles:

Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Lei Tao, Yue Zhou, Yuan Luo, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 21

Epigenetic Modulators as Therapeutic Agents in Cancer
Eshaan Patnaik, Chikezie O. Madu, Yi Lü
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14964-14964
Open Access | Times Cited: 24

Experimental Murine Models for Colorectal Cancer Research
Íris Neto, João Rocha, Maria Manuela Gaspar, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2570-2570
Open Access | Times Cited: 14

Distinct TYRO3 and PROS1 expression levels contribute to preeclampsia pathogenesis
Esma Konuk, Ertan Katırcı, Mehmet Şimşek
Histochemistry and Cell Biology (2025) Vol. 163, Iss. 1
Closed Access

Hua Zheng San Ji Fang suppresses liver cancer progression by inhibiting TYRO3 expression via the ERK signaling pathway
Zhuang Xiong, Xiaodan Sui, Yu Bai, et al.
Phytomedicine (2025) Vol. 139, pp. 156497-156497
Closed Access

Proteolysis of TAM receptors in autoimmune diseases and cancer: what does it say to us?
Ivana Malíková, Anastassiya Vetrova, Diana Aliyeva, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access

Epigenetic drivers of metalloproteinases and metastasis
Marco Seehawer, Kornélia Polyák
Trends in Cell Biology (2025)
Closed Access

Emerging roles of 3D-culture systems in tackling tumor drug resistance
Amin Nikdouz, Francesca Orso
Cancer Drug Resistance (2023) Vol. 6, Iss. 4, pp. 788-804
Open Access | Times Cited: 9

Genetic alterations shape innate immune cells to foster immunosuppression and cancer immunotherapy resistance
Louis Boafo Kwantwi
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4289-4296
Closed Access | Times Cited: 7

MERTK Inhibition as a Targeted Novel Cancer Therapy
K.M. Tanim, Alisha Holtzhausen, Aashis Thapa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7660-7660
Open Access | Times Cited: 2

Genetic correlation, shared loci, but no causality between bipolar disorder and inflammatory bowel disease: A genome-wide pleiotropic analysis
B. Wang, Jing Wang, Tian Tian, et al.
Journal of Affective Disorders (2023) Vol. 348, pp. 167-174
Closed Access | Times Cited: 5

The application of organoids in colorectal diseases
Yanxin Liu, Dongxu Wang, Yanhong Luan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

A Review of the Bromodomain and Extraterminal Domain Epigenetic Reader Proteins: Function on Virus Infection and Cancer
Mengli Wu, Guiquan Guan, Hong Yin, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1096-1096
Open Access | Times Cited: 1

CCZ1 Accelerates the Progression of Cervical Squamous Cell Carcinoma by Promoting MMP2/MMP17 Expression
Jing Yu, Zhenlong Yuan, Jing Liu, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1468-1468
Open Access

Ku70 Targets BRD3-MYC/Cyclin D1 Axis to Drive Hepatocellular Carcinoma Progression
Wenshuang Sun, Ji Cheng, Ruijun Zhao, et al.
Experimental Cell Research (2024) Vol. 444, Iss. 2, pp. 114404-114404
Closed Access

Page 1

Scroll to top